Dendritic Cells Promote T-cell Survival or Death Depending Upon Their Maturation State and Presentation of Antigen

References

• Rosenberg S A, Yang J C, Schwartzentruber D J, Hwu P, Marincola F M, Topalian S L, Restifo N P, Dudley M E, Schwarz S L, Spiess P J, Wunderlich J R, Parkhurst M R, Kawakami Y, Seipp C A, Einhorn J H, White DE. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med. 1998; 4(3)321–7
   PubMed Web of Science ®Google Scholar
• Lotze M T, Finn OJ. Cellular immunity and the immunotherapy of cancer. J Immunotherapy 1993; 14: 79–87
   Google Scholar
• Gilboa E, Nair S K, Lyerly HK. Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunol Immunother. 1998; Apr46((2))82–87
   Google Scholar
• Lotze M T, Shurin M, Davis I, Amoscato A, Storkus W J. Dendritic cell based therapy of cancer. Advances in Experimental Medicine & Biology 1997; 417: 551–569
   PubMedGoogle Scholar
• Kawakami Y, Eliyuha S, Delgado C H, Robbins P F, Sakkaguchi K, Appella E, Yanelli J R, Adema G J, Kimmi T, Rosenbergh SA. Identification of melanoma antigens recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci. 1994; 91: 6458–6462
   PubMed Web of Science ®Google Scholar
• Tjandrawan T, Martin D M, Maeurer M J, Castelli C, Lotze M T, Storkus WJ. Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs. J Immunother. 1998; 21(2)149–57
   PubMedGoogle Scholar
• Gabrilovich D I, Chen H L, Girgis K R, Cunningham H T, Meny G M, Nadaf S, Kavanaugh D, Carone DP. Production of vascular endothelial growth factor by human tumors inhuibits the functional maturation of dendritic cells. Nat. Med. 1996; 1096((10))103
   Google Scholar
• Chaux P., Favre N., Bonnotte B., Moutet M., Martin M., Martin F. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors. Advances in Experimental Medicine & Biology 1997; 417: 525–8
   PubMedGoogle Scholar
• Ishida T., Oyama T., Carbone DP, Gabrilovich DI. Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. Journal of Immunology 1998; 161(9)4842–51
   PubMedGoogle Scholar
• Esche C, Lokshin A, Shurin G V, Gastman B R, Rabinowich H, Watkins S C, Lotze M T, Shurin MR. Tumor's other immune targets: dendritic cells. J Leukoc Biol. 1999; 66(2)336–44
   PubMedGoogle Scholar
• Esway J, Shurin G V, Lotze M T, Barksdale EM. Creating immune privilege: Neuroblastoma soluble factors cause apoptosis of Fas-sensitive targets. Journal of Immunotherapy 1997; 20: 402
   Google Scholar
• Reichert T E, Rabinowich H, Johnson J T, Whiteside TL. Mechanisms responsible for signaling and functional defects. J Immunother. 1998; 21(4)295–306
   PubMedGoogle Scholar
• Whiteside TL. Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol Immunother. 1999; 48(7)346–352
   PubMedGoogle Scholar
• Kabelitz D, Janssen O. Antigen-induced death of T-Lymphocytes. Front Biosci. 1997; 2: 61–77
   PubMedGoogle Scholar
• Guéry J C, Adorini L. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class-II-restricted cells. Journal of Immunology 1995; 154: 536
   PubMed Web of Science ®Google Scholar
• Lui Y., Linsley P.S. Costimulation of T-cell Growth. Curr. Opin. Immunnol. 1992; 4: 265
   PubMedGoogle Scholar
• Lotze M T, Thomson AW. Dendritic cells. Biology and Clinical Applications. Academic Press, San Diego, pp.487–511
   Google Scholar
• Lu L, Qian S, Hershberger P A, Rudert W A, Lynch DH. Thomson AWF as ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol. 1997; 158(12)5676–84
   PubMedGoogle Scholar
• Lauritzsen G F, Hofgaard P O, Schenck K, Bogen B. Clonal deletion of thymocytes as a tumor escape mechanism. Int J Cancer 1998; 78(2)216–22
   PubMedGoogle Scholar
• Enk A H, Jonuleit H, Saloga J, Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. International Journal of Cancer 1997; 73: 309–16
   PubMed Web of Science ®Google Scholar
• Daniel P T, Scholz C, Westermann J, Dorken B, Pezzutto A. Dendritic cells prevent CD95 Mediated T lymphocyte death through costimulatory signals. Adv. Exp. Med. Biol. 1998; 451: 173–7
   PubMed Web of Science ®Google Scholar
• Bjorck P, Banchereau J, Flores-Romo L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int Immunol 1997; 9(3)365–72
   PubMedGoogle Scholar
• Bennett S R, Carbone F R, Karamalis F, Flavell R A, Miller J F, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 1998; 393: 478–480
   PubMed Web of Science ®Google Scholar
• Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulator capacity: T-T help via APC activation. J of Exp Med. 1996; 184: 747–752
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 1997; 27(12)3135–42
   PubMed Web of Science ®Google Scholar
• Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods. 1991; 145(1–2)185–92
   PubMedGoogle Scholar
• Albert M L, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392(6671)86–9
   PubMed Web of Science ®Google Scholar
• Albert M L, Pearce S F, Francisco L M, Sauter B, Roy P, Silverstein R L, Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36 and cross-present antigens to cytotoxic T lymphocytes. JExpMed. 1998; 188(7)1359–68
   Google Scholar
• Rovere P, Vallinoto C, Bondanza A, Crosti M C, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, Manfredi AA. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol. 1998; 161(9)4467–71
   PubMed Web of Science ®Google Scholar
• Thomas RL, Jr, Matsko C M, Lotze M T, Amoscato AA. Mass Spectrometric Identification of Increased C16 Ceramide Levels During Apoptosis. J Biol Chem. 1999; 274(43)30580–30588
   PubMedGoogle Scholar
• Poot M, Pierce RH. Detection of changes in mitochondrial function during apoptosis by simultaneous staining with multiple fluorescent dyes and correlated multiparameter flow cytometry. Cytometry 1999; 35(4)311–7
   PubMedGoogle Scholar
• Zeid N A, Muller H. K. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 1993; 25: 338
   PubMed Web of Science ®Google Scholar
• Furihata M, Ohtsuki Y, Ido E, Iwata J, Sonobe H, Araki K, Ogoshi S, Ohmori K. HLA-DR antigen-and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma—their distribution in relation to prognosis. Virchows Archiv. B 1992; 61: 409
   Google Scholar
• Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K. Infiltration of dendritic cells in relationship to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 1990; 66: 2012
   PubMedGoogle Scholar
• Giannini A, Bianchi S, Messerini L, Gallo O, Gallina E, Asprella Libonati G., Olmi P, Zampi G. Prognostic significance of accessory cells and lymphocytes in nasopharygeal carcinoma. Pathol. Res. Pract. 1991; 187: 496
   PubMed Web of Science ®Google Scholar
• Bigotti G, Coli A, Castagnola D. Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade. Prostate 1991; 19(1)73–87
   PubMedGoogle Scholar
• Evans E M, Man S, Evans A S, Borysiewicz LK. Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res. 1997; 57(14)2943–2950
   PubMedGoogle Scholar
• Goldman SA, Baker E, Weyant RJ, Clarke MR, Myers JN, Lotze MT, Peritumoral CD. La-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Archives of Otolaryngology—Head & Neck Surgery. 1998; 124(6)641–6
   PubMedGoogle Scholar
• Hashimoto W, Osaki T, Okamura H, Robbins P D, Kurimoto M, Nagata S, Lotze M T, Tahara H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand-and perforin-induced tumor apoptosis respectively. J Immunol. 1999; 163(2)583–9
   PubMed Web of Science ®Google Scholar
• Gardella S, Andrei C, Costigliolo S, Poggi A, Zocchi MR, Rubartclli A. Interleukin-18 synthesis and secretion by dendritic cells are modulated by interaction with antigen-specific cells. Journal of Leukocyte Biology 1999; 66(2)237–4
   PubMed Web of Science ®Google Scholar